AlphaCrest Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,271
Closed -$783K 1258
2022
Q2
$783K Sell
14,271
-3,218
-18% -$186K 0.04% 772
2022
Q1
$1.32M Sell
17,489
-5,232
-23% -$357K 0.07% 418
2021
Q4
$1.69M Sell
22,721
-12,398
-35% -$735K 0.06% 515
2021
Q3
$1.65M Buy
35,119
+8,700
+33% +$378K 0.09% 386
2021
Q2
$1.07M Buy
26,419
+17,619
+200% +$730K 0.05% 634
2021
Q1
$362K Buy
+8,800
New +$328K 0.02% 947

Other funds holding ACLS

AlphaCrest Capital Management's ACLS Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Axcelis (ACLS) in Q3 2022, closing a stake of 14,271 shares — an estimated $783K sold.

AlphaCrest Capital Management first reported a position in ACLS in Q1 2021 and held it in 6 quarters. The position peaked at $1.69M in Q4 2021. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Axcelis position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 14,271 Axcelis shares in Q3 2022, an estimated $783K.
  • AlphaCrest Capital Management first reported a position in Axcelis in Q1 2021 and held it in 6 quarters.
  • AlphaCrest Capital Management's Axcelis position peaked at $1.69M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.